The Blood Revolution: How Liquid Biopsy is Transforming Oncology, from Early Detection to Real-Time Treatment Monitoring.
The advent of **liquid biopsy** represents a paradigm shift in oncology, moving away from invasive and often risky surgical tissue biopsies toward a simple blood draw. This revolutionary non-invasive technique analyzes circulating biomarkers—such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs)—present in bodily fluids. The primary...
0 Comments 0 Shares 606 Views